Search
Menu
Home
Sources
About
Contacts
Sibrotuzumab
Sibrotuzumab
is a
humanized monoclonal antibody
intended
for the
treatment of cancer
. It
binds
to
FAP
In
2003
it
failed
a
phase
II
clinical trial
for
metastatic colorectal cancer
.